Pandemic Preparedness: Developing Vaccinesand Therapeutic Antibodies For COVID-19

Type Journal Article Author Gregory D. Sempowski Author Kevin O. Saunders Author Priyamvada Acharya Author Kevin J. Wiehe Author Barton F. Haynes URL https://www.cell.com/cell/pdf/S0092-8674(20)30674-7.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420306747%3Fshowall%3Dtrue Series Cell Leading Edge | Perspective Volume 181 Publication Cell Press Date 27/05/2020 DOI https://doi.org/10.1016/j.cell.2020.05.041 Abstract The SARS-CoV-2 pandemic that causes COVID-19 respiratory syndrome has caused global publichealth and economic crises, necessitating rapid development of vaccines and therapeutic counter-measures. The world-wide response to the COVID-19 pandemic has been unprecedented withgovernment, academic, and private partnerships working together to rapidly develop vaccineand antibody countermeasures. Many of the technologies being used are derived from prior gov-ernment-academic partnerships for response to other emerging infections